Nasal Mask Kit in Gastrointestinal Endoscopy
- Conditions
- Gastric PolypColon PolypHypoxiaGastric CancerColon CancerEsophageal Cancer
- Interventions
- Device: nasal mask oxygen kitDevice: regular nasal cannula
- Registration Number
- NCT05405530
- Lead Sponsor
- RenJi Hospital
- Brief Summary
Hypoxia is the most common adverse event in gastrointestinal endoscopes sedated with propofol. The nasal mask oxygen kit has good sealing to ensure an adequate oxygen supply and is convenient and economical.The aim of this randomized study was to determine whether the nasal mask oxygen kit reduces the incidence of hypoxia in gastrointestinal endoscopes procedures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1200
- 18≤ Age ≤60
- patients undergoing combined gastroendoscopy and colonoscopy procedure
- patients signed informed consent form
- ASA classification I-II
- Estimated procedure time <=45min
- Coagulation disorders or a tendency of nose bleeding
- Diagnosed heart disease (heart failure, angina, myocardial infarction, arrhythmia, etc.)
- Diagnosed chronic obstructive pulmonary disease or current other acute or chronic lung disease requiring supplemental chronic or intermittent oxygen therapy)
- hypoxia (SpO2< 90 % )
- Upper respiratory tract infection
- increased intracranial pressure
- Fever (core body temperature >37.5 ℃)
- Pregnancy, breastfeeding, or positive pregnancy test
- Emergency procedure or surgery
- Multiple trauma
- Allergy to propofol or tape and adhesives
- BMI<18.5 or BMI>30
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description nasal mask oxygen group nasal mask oxygen kit In this group, patients use the nasal mask oxygen kit for oxygenation. regular nasal cannula group regular nasal cannula In this group, patients use the regular nasal cannula for oxygenation.
- Primary Outcome Measures
Name Time Method The incidence of hypoxia Patients will be followed for the duration of hospital stay, an expected average about 2 hours] (75% ≤ SpO2 \< 90% for \<60 s)
- Secondary Outcome Measures
Name Time Method The incidence of severe hypoxia Patients will be followed for the duration of hospital stay, an expected average about 2 hours (SpO2 \< 75% or 75% ≤ SpO2 \< 90% for \>/=60 s)
The incidence of other adverse events Patients will be followed for the duration of hospital stay, an expected average about 2 hours] Other adverse events recorded by tools proposed by the World Society of Intravenous Anesthesia International Sedation Task Force
The incidence of sub-clinical respiratory depression Patients will be followed for the duration of hospital stay, an expected average about 2 hours] (90% ≤ SpO2 \< 95%)
Trial Locations
- Locations (3)
Henan Provincial People's Hospital
🇨🇳Zhengzhou, Henan, China
First Affiliated Hospital of Kunming Medical University
🇨🇳Kunming, Yunnan, China
Renji Hospital
🇨🇳Shanghai, Shanghai, China